Blocking of histamine H2 receptors enhances parietal cell degeneration in the mouse stomach

S M Karam1, G Alexander

  • 1Department of Anatomy, Faculty of Medicine, Kuwait University. karam@hsc.kuniv.edu.kw

Insights

Ranitidine, a histamine H2 receptor antagonist, causes parietal cell damage and vacuolation in mice. However, the stomach rapidly recovers after treatment cessation, with increased pre-parietal cell production aiding regeneration.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Histology

Background:

  • Parietal cells are crucial for gastric acid secretion.
  • Histamine H2 receptor antagonists are widely used to reduce stomach acid.
  • The long-term effects of these antagonists on parietal cell lineage require further investigation.

Purpose of the Study:

  • To investigate the impact of ranitidine on mouse parietal cell lineage.
  • To characterize morphological changes in parietal cells following ranitidine exposure.
  • To assess the regenerative capacity of parietal cells after ranitidine withdrawal.

Main Methods:

  • Mice were infused with ranitidine for varying durations (15, 30, 42 hours).
  • Light and electron microscopy were used to examine parietal cell morphology.
  • Cells were categorized as normal, altered (vacuolation, dilated canaliculi), or damaged (necrosis, apoptosis).

Main Results:

  • Ranitidine treatment led to a dose-dependent increase in altered and damaged parietal cells.
  • Parietal cell vacuolation and damage increased with infusion duration.
  • An increase in pre-parietal cells was observed, correlating with ranitidine exposure.
  • Following a 4-day recovery period, gastric glands normalized, and damaged cells disappeared.

Conclusions:

  • Ranitidine inhibits acid secretion by blocking histamine H2 receptors, leading to parietal cell degeneration.
  • Ranitidine also stimulates the production of pre-parietal cells, facilitating prompt population recovery.
  • The mouse stomach demonstrates significant regenerative potential after ranitidine-induced injury.

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.